Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lock

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Seizure|November 12, 2021
Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndromeJ Helen Cross, Bradley S Galer, Antonio Gil-Nagel, et al.
Clinical Breast Cancer|June 12, 2019
Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving RadiotherapySelina Chow, Bo Angela Wan, William Pidduck, et al.
Clinical and Translational Radiation Oncology|February 6, 2020
DCE-MRI assessment of response to neoadjuvant SABR in early stage breast cancer: Comparisons of single versus three fraction schemes and two different imaging time delays post-SABRMatthew Mouawad, Heather Biernaski, Muriel Brackstone, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2019
Reducing the dose of gadolinium-based contrast agents for DCE-MRI guided SBRT: The effects on inter and intra observer variability for preoperative target volume delineation in early stage breast cancer patientsMatthew Mouawad, Heather Biernaski, Muriel Brackstone, et al.
Future Oncology (London, England)|September 5, 2015
The development of stereotactic body radiotherapy in the past decade: a global perspectiveSimon S Lo, Ben J Slotman, Michael Lock, et al.
Expert Review of Anticancer Therapy|March 22, 2016
Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directionsSten Myrehaug, Arjun Sahgal, Suzanne M Russo, et al.
BMJ Supportive & Palliative Care|January 31, 2025
Enteral and parenteral nutrition in patients with cancer: complication rates compared-updated systematic review and meta-analysisRonald Chow, James H B Im, Jann Arends, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2026
Practical Aspects of Delivering Radiation for Poly-metastatic DiseaseHatim Fakir, Gage Redler, Glenn S Bauman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2024
Diagnostic CT-Enabled Planning (DART): Results of a Randomized Trial in Palliative Radiation TherapyMelissa O'Neil, Joanna M Laba, Timothy K Nguyen, et al.
BMC Cancer|July 25, 2012
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trialDavid A Palma, Cornelis J A Haasbeek, George B Rodrigues, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Seizure|November 12, 2021
Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndromeJ Helen Cross, Bradley S Galer, Antonio Gil-Nagel, et al.
Clinical Breast Cancer|June 12, 2019
Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving RadiotherapySelina Chow, Bo Angela Wan, William Pidduck, et al.
Clinical and Translational Radiation Oncology|February 6, 2020
DCE-MRI assessment of response to neoadjuvant SABR in early stage breast cancer: Comparisons of single versus three fraction schemes and two different imaging time delays post-SABRMatthew Mouawad, Heather Biernaski, Muriel Brackstone, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2019
Reducing the dose of gadolinium-based contrast agents for DCE-MRI guided SBRT: The effects on inter and intra observer variability for preoperative target volume delineation in early stage breast cancer patientsMatthew Mouawad, Heather Biernaski, Muriel Brackstone, et al.
Future Oncology (London, England)|September 5, 2015
The development of stereotactic body radiotherapy in the past decade: a global perspectiveSimon S Lo, Ben J Slotman, Michael Lock, et al.
Expert Review of Anticancer Therapy|March 22, 2016
Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directionsSten Myrehaug, Arjun Sahgal, Suzanne M Russo, et al.
BMJ Supportive & Palliative Care|January 31, 2025
Enteral and parenteral nutrition in patients with cancer: complication rates compared-updated systematic review and meta-analysisRonald Chow, James H B Im, Jann Arends, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2026
Practical Aspects of Delivering Radiation for Poly-metastatic DiseaseHatim Fakir, Gage Redler, Glenn S Bauman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2024
Diagnostic CT-Enabled Planning (DART): Results of a Randomized Trial in Palliative Radiation TherapyMelissa O'Neil, Joanna M Laba, Timothy K Nguyen, et al.
BMC Cancer|July 25, 2012
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trialDavid A Palma, Cornelis J A Haasbeek, George B Rodrigues, et al.
Pageof 17